Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Diabetes Risk”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02982408
What this trial is testing

Impact of Overfeeding and Following Exercise Training in Individuals With and Without Increased Risk of Type 2 Diabetes

Who this might be right for
Type 2 Diabetes MellitusInsulin ResistanceDyslipidemia
Rigshospitalet, Denmark 48
Not applicableStudy completedNCT02289612
What this trial is testing

Glycemic and Satiety Response Study of Fibre-Enriched Pudding Products

Who this might be right for
Type 2 Diabetes Mellitus
University of Guelph 15
Not applicableUnknownNCT04986345
What this trial is testing

High-intensity Interval Training Prescriptions to Reduce the Risk of Complications Linked to Type 2 Diabetes: the Role of Interval Length on Clinical Benefits and on Physiological Mechanisms

Who this might be right for
Diabetes Mellitus, Type 2
Université de Sherbrooke 15
Not applicableLooking for participantsNCT06822439
What this trial is testing

Remote Fetal Monitoring in High Risk Pregnancies

Who this might be right for
High Risk PregnancyRemote Patient MonitoringDiabetes+1 more
Beth Israel Deaconess Medical Center 50
Not applicableLooking for participantsNCT06976073
What this trial is testing

Non-invasive Imaging for In-vivo Quantification of Skin Composition and Structure

Who this might be right for
Diabetes Mellitus, Type 2Diabetic FootPeripheral Arterial Disease+2 more
HJN Sverige AB/Neko Health 8,000
Not applicableStudy completedNCT02316054
What this trial is testing

Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)

Who this might be right for
Type 2 Diabetes
University Hospital, Grenoble 170
Post-approval studies (Phase 4)Study completedNCT00442325
What this trial is testing

Benefits Of Using Various Starting Doses Of Atorvastatin On Achievement Of Cholesterol Targets

Who this might be right for
Coronary ArteriosclerosisDiabetes Mellitus, Type 2Cerebrovascular Accident+2 more
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 595
Not applicableUnknownNCT01608620
What this trial is testing

Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease

Who this might be right for
OverweightObesityDyslipidemia+9 more
John Sievenpiper 1
Large-scale testing (Phase 3)Study completedNCT00829296
What this trial is testing

Safety Study to Lower the Risk of Heart Failure is Also Effective in Reducing Stiffness of the Arteries

Who this might be right for
HypertensionDiabetes
University of Chicago 70
Not applicableLooking for participantsNCT07254689
What this trial is testing

The Food for Health Study

Who this might be right for
Type 2 DiabetesFood InsecurityRural Health
University of Montana 43
Not applicableUnknownNCT00989924
What this trial is testing

Research on the Correlation Among Magnetocardiography Patterns and Known Cardiovascular Risk Factors in Diabetic Patients

Who this might be right for
Diabetes Mellitus
National Taiwan University Hospital 1,100
Large-scale testing (Phase 3)Looking for participantsNCT07797335
What this trial is testing

AMBITION 7: A Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Insulin Glargine in People With Type 2 Diabetes and Increased Risk of Diseases That Affect the Heart and Blood Vessels Treated With 1-3 Other Diabetes Medications

Who this might be right for
Type 2 DiabetesCardiovascular Risk
Novo Nordisk A/S 1,778
Testing effectiveness (Phase 2)Study completedNCT01589835
What this trial is testing

Preventing Diabetes in Those at Risk by Having a Facilitator and Family Doctor Encourage Healthy Activity and Eating Habits

Who this might be right for
Prediabetes
University of British Columbia 59
Not applicableStudy completedNCT02299791
What this trial is testing

Dissemination of CVD Risk Factor Treatment Among Diabetic Patients in Safety Net Clinics

Who this might be right for
Diabetes MellitusCardiovascular Diseases
Kaiser Permanente 4,856
Post-approval studies (Phase 4)Ended earlyNCT00651378
What this trial is testing

Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)

Who this might be right for
HypercholesterolemiaAtherosclerosisCoronary Artery Disease
Organon and Co 87
Not applicableUnknownNCT01762085
What this trial is testing

Nerve Decompression for Ulcer Recurrence Avoidance (DURA)

Who this might be right for
Diabetic Ulcer of Plantar Aspect of Left FootDiabetic Ulcer of Plantar Aspect of Right FootDiabetic Polyneuropathy
Association of Extremity Nerve Surgeons 120
Not applicableStudy completedNCT02763943
What this trial is testing

Improving Medication Safety and CVD Risk Factor Control in Kidney Transplant Recipients

Who this might be right for
Cardiovascular DiseasesDiabetes MellitusMedication Adherence
Medical University of South Carolina 60
Not applicableEnded earlyNCT01315808
What this trial is testing

Rate of Change of HbA1c (dx/dt) May Predict Progression to Type 2 DM

Who this might be right for
Diabetes Mellitus Type 2
Wyckoff Heights Medical Center 542
Not applicableStudy completedNCT00006165
What this trial is testing

Native Hawaiian Diabetes Intervention Program

Who this might be right for
Diabetes Mellitus, Type 2
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Not applicableStudy completedNCT01079195
What this trial is testing

Effectiveness and Tolerability of Tarka® in the Treatment of Hypertensive Patients With High Risk of Developing Diabetes Mellitus

Who this might be right for
Hypertension
Abbott 15,436
Next Page